848 related articles for article (PubMed ID: 18000217)
21. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
23. Clinical validation of a customized multiple signature microarray for breast cancer.
Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
[TBL] [Abstract][Full Text] [Related]
24. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
Webster LR; Lee SF; Ringland C; Morey AL; Hanby AM; Morgan G; Byth K; Mote PA; Provan PJ; Ellis IO; Green AR; Lamoury G; Ravdin P; Clarke CL; Ward RL; Balleine RL; Hawkins NJ
Clin Cancer Res; 2008 Oct; 14(20):6625-33. PubMed ID: 18927304
[TBL] [Abstract][Full Text] [Related]
25. Limits of predictive models using microarray data for breast cancer clinical treatment outcome.
Reid JF; Lusa L; De Cecco L; Coradini D; Veneroni S; Daidone MG; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2005 Jun; 97(12):927-30. PubMed ID: 15956654
[TBL] [Abstract][Full Text] [Related]
26. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
[TBL] [Abstract][Full Text] [Related]
27. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
28. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
Marchiò C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
[TBL] [Abstract][Full Text] [Related]
30. Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor.
Kun Y; How LC; Hoon TP; Bajic VB; Lam TS; Aggarwal A; Sze HG; Bok WS; Yin WC; Tan P
Hum Mol Genet; 2003 Dec; 12(24):3245-58. PubMed ID: 14570715
[TBL] [Abstract][Full Text] [Related]
31. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
32. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
33. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
Culhane AC; Perrière G; Higgins DG
BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients.
Györffy B; Schäfer R
Breast Cancer Res Treat; 2009 Dec; 118(3):433-41. PubMed ID: 19052860
[TBL] [Abstract][Full Text] [Related]
35. [Gene expression profiling of ER+ breast cancers: to discriminate the poor prognosis tumors or to define the most suitable treatment?].
Chanrion M; Darbon JM
Bull Cancer; 2008 May; 95(5):513-8. PubMed ID: 18541515
[TBL] [Abstract][Full Text] [Related]
36. Tumor classification ranking from microarray data.
Hewett R; Kijsanayothin P
BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S21. PubMed ID: 18831787
[TBL] [Abstract][Full Text] [Related]
37. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
38. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a transcriptional signature of breast cancer.
Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
Hayes DN; Monti S; Parmigiani G; Gilks CB; Naoki K; Bhattacharjee A; Socinski MA; Perou C; Meyerson M
J Clin Oncol; 2006 Nov; 24(31):5079-90. PubMed ID: 17075127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
